Liver and biliary tract cancer trials in Israel

In Israel 9 Also abroad 1314

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Observational Study Protocol: LIVER-R
Where
Jerusalem, Nahariya, Ramat Gan, Tel Aviv
Age
18 years to 130 years
People
4,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06252753
Phase 3Taking people
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan, HaMerkaz, Tel Aviv
Age
18 years and over
People
286 worldwide
Run by
Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00
Phase 1Taking people
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Where
Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years and over
People
325 worldwide
Run by
AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Beersheba, Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tsrifin
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 1Taking people
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Where
Haifa, Jerusalem, Petah Tikva
Age
18 years and over
People
232 worldwide
Run by
AbbVie
See details and how to joinNCT06858813 · EU 2024-518012-39-00
Phase 1/2Taking people
Safety of HRX215 in Patients After Minor and Major Liver Resection
Where
Petah Tikva, Ramat Gan, Tel Aviv
Age
18 years to 75 years
People
80 worldwide
Run by
HepaRegeniX GmbH
See details and how to joinNCT06638502
No phaseTaking people
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Where
Tel Aviv
Age
18 years and over
People
300
Run by
Daniel Keizman
See details and how to joinNCT07485114
No phaseEnrolling by invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
Where
Petach Tikvah
Age
1 day and over
People
500 worldwide
Run by
Prof. Valérie Mc Lin
See details and how to joinNCT06041906
Phase 3Taking people
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Where
Petah Tikva
Age
18 years and over
People
471 worldwide
Run by
Can-Fite BioPharma
See details and how to joinNCT05201404